Commonwealth Equity Services, LLC Agenus Inc Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$0.53 - $0.93 $2,319 - $4,069	4,376 Added 40.71%	15,126 $9,000
Q4 2023 Feb 06, 2024	SELL	$0.63 - $1.14 $551 - $997	-875 Reduced 7.53%	10,750 $9,000
Q3 2023 Oct 23, 2023	SELL	$1.12 - $1.88 $560 - $940	-500 Reduced 4.12%	11,625 $13,000
Q2 2023 Aug 10, 2023	BUY	$1.31 - $2.04 $1,310 - $2,040	1,000 Added 8.99%	12,125 $19,000
Q1 2023 May 11, 2023	SELL	$1.45 - $2.95 $290 - $590	-200 Reduced 1.77%	11,125 $16,000
Q4 2022 Feb 07, 2023	SELL	$2.02 - $3.25 $3,032 - $4,878	-1,501 Reduced 11.7%	11,325 $27,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $25,138 - $40,273	12,826 New	12,826 $26,000
Q1 2022 May 04, 2022	SELL	$2.35 - $3.47 $27,544 - $40,671	-11,721 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$2.92 - $5.74 $31,830 - $62,571	-10,901 Reduced 48.19%	11,721 $37,000
Q3 2021 Oct 29, 2021	BUY	$4.98 - $6.63 $12,454 - $16,581	2,501 Added 12.43%	22,622 $118,000
Q2 2021 Aug 11, 2021	BUY	$2.56 - $5.49 $2,560 - $5,490	1,000 Added 5.23%	20,121 $110,000
Q1 2021 May 04, 2021	SELL	$2.69 - $5.25 $12,107 - $23,630	-4,501 Reduced 19.05%	19,121 $52,000
Q4 2020 Feb 11, 2021	BUY	$3.17 - $4.49 $34,873 - $49,394	11,001 Added 87.16%	23,622 $75,000
Q3 2020 Nov 05, 2020	BUY	$2.98 - $5.2 $7,450 - $13,000	2,500 Added 24.7%	12,621 $50,000
Q4 2019 Feb 05, 2020	SELL	$2.41 - $4.4 $976 - $1,782	-405 Reduced 3.85%	10,121 $41,000
Q3 2019 Oct 30, 2019	BUY	$2.17 - $3.14 $22,841 - $33,051	10,526 New	10,526 $27,000
Q1 2018 May 14, 2018	SELL	$3.51 - $6.04 $36,949 - $63,583	-10,527 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$3.26 - $4.78 $34,318 - $50,319	10,527	10,527 $34,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account